Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-23-047525)

Filing Details

Accession Number:: 0001209191-23-047525
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2023-08-28 16:42:02
Reporting Period:: 2023-08-24

Accepted Time:: 2023-08-28 16:42:02
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1740279	In8Bio Inc.	INAB	Biological Products, (No Disgnostic Substances) (2836)	825462585

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1830914	Tai-Wei William Ho	C/O In8Bio, Inc. 350 5Th Ave. Suite 5330 New York NY 10118	President And Ceo	Yes	Yes	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2023-08-24	23,800	$1.05	2,339,545	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	72,999	Indirect	By child
Common Stock	73,000	Indirect	By child
Common Stock	36,500	Indirect	See footnote
Common Stock	36,500	Indirect	See footnote
Common Stock	36,500	Indirect	See footnote

Footnotes

The shares are held by a relative of the Reporting Person. The Reporting Person has voting power pursuant to a voting proxy.